Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN108467396B reveals a microwave-assisted route for high-purity ganciclovir, offering significant cost reduction in pharmaceutical manufacturing and improved supply chain reliability.
Optimized synthesis of Palbociclib intermediate via trace palladium catalysis. Reduces heavy metal waste and manufacturing costs for reliable pharmaceutical supply chains.
Novel patent CN103965190A offers high-purity pharmaceutical intermediates via mild conditions. Reduces cost and ensures supply chain reliability for global buyers.
Novel Curtius rearrangement method for 4-amino-2,6-dichloropyridine. High purity, avoids explosive azides. Ideal for API manufacturing.
Patent CN106589017A offers water-based synthesis reducing waste significantly. Enhances supply chain reliability and cost efficiency for global buyers seeking stable sources.
Novel silver-catalyzed one-pot synthesis of 2(1H)-quinolinones using CO2. Offers safe, scalable pharmaceutical intermediate manufacturing with reduced toxicity.
Patent CN1032134C reveals a polyol-carrier strategy for Gemfibrozil, eliminating azeotropes and enhancing purity for reliable pharmaceutical intermediate supply chains.
Patent CN103755667A reveals a novel organocatalytic route for chiral tetrahydrofurans, offering superior enantioselectivity and scalable manufacturing for global API supply chains.
Patent CN112321609A reveals improved antibiotic synthesis. Achieve cost reduction and supply chain reliability with high-purity cephalosporin intermediates.
Novel molybdenum-catalyzed route for 10H-indolo[1,2-a]indole offers cost-effective scalable production for pharmaceutical intermediates supply chains.
Novel patent CN104557600B offers streamlined Sacubitril synthesis. Enhances supply chain reliability and reduces manufacturing complexity for global pharmaceutical partners.
Patent CN102875453B details a novel synthesis route for anticancer intermediates. This method offers significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN104447602B reveals high-purity synthesis. Offers cost reduction and supply reliability for pharmaceutical intermediates manufacturing.
Patent CN106892950B reveals a green route to >98% Troxerutin using sodium alginate, offering cost-effective API intermediate manufacturing.
Patent CN108997233B reveals a one-pot tandem reaction for high-purity triazole intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN1810774A reveals efficient catalytic hydrogenation for pharmaceutical intermediate recovery, reducing waste and enhancing supply chain stability significantly.
Patent CN104447434B details a green catalytic oxidation method for p-carboxybenzenesulfonamide. Offers high purity, reduced waste, and scalable manufacturing for reliable pharmaceutical intermediate supply chains.
Patent CN1761658A details a novel solubility-based purification for 1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile, ensuring superior supply chain reliability.
Patent CN113004202B reveals optimized process for high purity Tolvaptan. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN1207287C reveals a streamlined synthesis for Candesartan Cilexetil intermediates, offering significant cost reduction in pharmaceutical manufacturing through simplified late-stage coupling.